Investigação da atividade antifúngica e anti-biofilme de 2-cloro-n-fenilacetamida sobre Candida albicans e Candida parapsilosis resistentes ao fluconazol

Detalhes bibliográficos
Autor(a) principal: Diniz Neto, Hermes
Data de Publicação: 2022
Tipo de documento: Tese
Idioma: por
Título da fonte: Biblioteca Digital de Teses e Dissertações da UFPB
Texto Completo: https://repositorio.ufpb.br/jspui/handle/123456789/26118
Resumo: Infections caused by the Candida genus, especially systemic ones, represent a challenge for public health due to high morbidity and mortality, high associated costs and difficulty in treatment with a good clinical prognosis. Candida albicans is the most frequent cause of this infection, however, the number of cases caused by non-albicans species such as C. parapsilosis has emerged, with a remarkable record of resistant strains. The search for new therapeutic alternatives becomes an important resource in the control of these infections and the use of some already known substances, such as 2-chloro-N-phenylacetamide, is a way to obtain potentially effective new products. Therefore, the antifungal potential of 2-chloro-N-phenylacetamide was investigated against fluconazole-resistant C. albicans and C. parapsilosis strains. The antifungal activity of 2-chloro-N-phenylacetamide was evaluated in vitro by the determination of the minimum inhibitory and fungicidal concentrations (MIC and MFC), inhibition of biofilm formation and its rupture, investigation of the possible mechanism of action, and association between this molecule and amphotericin B and fluconazole. The test product inhibited all strains of C. albicans and C. parapsilosis, with a MIC ranging from 128 to 256 μg.mL-1, and a MFC of 512 to 1,024 μg.mL-1. It also inhibited up to 92% of biofilm formation and rupture of up to 87% of preformed biofilm. However, 2-chloro-N-phenylacetamide did not promote antifungal activity by binding to cell membrane ergosterol, nor did it impair the integrity of the fungal cell wall. Antagonism has been observed when combining this substance with amphotericin B and fluconazole. The substance exhibited significant antifungal effects by inhibiting both planktonic cells and the biofilm of fluconazole-resistant strains. It is worth noting that its combination with other antifungals should be avoided and that its mechanism of action remains to be established.
id UFPB_cc40d4439840c1e3f3864e2fd773ff64
oai_identifier_str oai:repositorio.ufpb.br:123456789/26118
network_acronym_str UFPB
network_name_str Biblioteca Digital de Teses e Dissertações da UFPB
repository_id_str
spelling Investigação da atividade antifúngica e anti-biofilme de 2-cloro-n-fenilacetamida sobre Candida albicans e Candida parapsilosis resistentes ao fluconazolFungicidas2-cloro-N-fenilacetamidaBiofilmeCandida spp.Resistência antifúngicaFungicides2-chloro-N-phenylacetamideBiofilmAntifungal resistanceMecanismo de açãoMechanism of actionCNPQ::CIENCIAS BIOLOGICAS::FARMACOLOGIAInfections caused by the Candida genus, especially systemic ones, represent a challenge for public health due to high morbidity and mortality, high associated costs and difficulty in treatment with a good clinical prognosis. Candida albicans is the most frequent cause of this infection, however, the number of cases caused by non-albicans species such as C. parapsilosis has emerged, with a remarkable record of resistant strains. The search for new therapeutic alternatives becomes an important resource in the control of these infections and the use of some already known substances, such as 2-chloro-N-phenylacetamide, is a way to obtain potentially effective new products. Therefore, the antifungal potential of 2-chloro-N-phenylacetamide was investigated against fluconazole-resistant C. albicans and C. parapsilosis strains. The antifungal activity of 2-chloro-N-phenylacetamide was evaluated in vitro by the determination of the minimum inhibitory and fungicidal concentrations (MIC and MFC), inhibition of biofilm formation and its rupture, investigation of the possible mechanism of action, and association between this molecule and amphotericin B and fluconazole. The test product inhibited all strains of C. albicans and C. parapsilosis, with a MIC ranging from 128 to 256 μg.mL-1, and a MFC of 512 to 1,024 μg.mL-1. It also inhibited up to 92% of biofilm formation and rupture of up to 87% of preformed biofilm. However, 2-chloro-N-phenylacetamide did not promote antifungal activity by binding to cell membrane ergosterol, nor did it impair the integrity of the fungal cell wall. Antagonism has been observed when combining this substance with amphotericin B and fluconazole. The substance exhibited significant antifungal effects by inhibiting both planktonic cells and the biofilm of fluconazole-resistant strains. It is worth noting that its combination with other antifungals should be avoided and that its mechanism of action remains to be established.Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPESInfecções causadas pelo gênero Candida, sobretudo as sistêmicas, representam um desafio para a saúde pública devido à alta morbimortalidade, elevados custos associados e dificuldade de tratamento com bom prognóstico clínico. Candida albicans é a mais frequente causadora desta infecção, entretanto, o número de casos provocados por espécies não-albicans como C. parapsilosis tem surgido, com notável registro de linhagens resistentes. A busca por novas alternativas terapêuticas se torna um recurso importante no controle destas infecções e o aproveitamento de algumas substâncias já conhecidas, como a 2-cloro-N-fenilacetamida, é uma maneira de se obter novos produtos potencialmente eficazes. Diante disto, o potencial antifúngico da 2-cloro-N-fenilacetamida foi investigado contra linhagens de C. albicans e C. parapsilosis resistentes a fluconazol. A atividade antifúngica da 2-cloro-N-fenilacetamida foi avaliada in vitro pela determinação da concentração inibitória e fungicida mínima (CIM e CFM), inibição da formação de biofilme e sua ruptura, investigação de provável mecanismo de ação e associação desta molécula com anfotericina B e fluconazol. O produto teste inibiu o crescimento de todas as cepas de C. albicans e C. parapsilosis, com uma CIM variando de 128 a 256 μg.mL-1, e uma CFM de 512 a 1.024 μg.mL-1. A substância também inibiu até 92% da formação de biofilme e provocou uma ruptura de até 87% do biofilme pré-formado. Porém, a 2-cloro-N-fenilacetamida não promoveu atividade antifúngica através da ligação ao ergosterol da membrana celular nem prejudicou a integridade da parede celular do fungo. O antagonismo foi observado ao combinar esta substância com anfotericina B e fluconazol. A substância exibiu efeitos antifúngicos significativos inibindo tanto as células planctônicas quanto o biofilme de cepas resistentes ao fluconazol. Vale salientar que sua combinação com outros antifúngicos deve ser evitada e que ainda resta estabelecer seu mecanismo de ação.Universidade Federal da ParaíbaBrasilFarmacologiaPrograma de Pós-Graduação em Produtos Naturais e Sintéticos BioativosUFPBLima, Edeltrudes de Oliveirahttp://lattes.cnpq.br/9406572870167006Guerra, Felipe Queiroga Sarmentohttp://lattes.cnpq.br/4997951182162954Diniz Neto, Hermes2023-01-31T20:44:09Z2022-11-192023-01-31T20:44:09Z2022-10-21info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/doctoralThesishttps://repositorio.ufpb.br/jspui/handle/123456789/26118porAttribution-NoDerivs 3.0 Brazilhttp://creativecommons.org/licenses/by-nd/3.0/br/info:eu-repo/semantics/openAccessreponame:Biblioteca Digital de Teses e Dissertações da UFPBinstname:Universidade Federal da Paraíba (UFPB)instacron:UFPB2023-05-22T16:32:12Zoai:repositorio.ufpb.br:123456789/26118Biblioteca Digital de Teses e Dissertaçõeshttps://repositorio.ufpb.br/PUBhttp://tede.biblioteca.ufpb.br:8080/oai/requestdiretoria@ufpb.br|| diretoria@ufpb.bropendoar:2023-05-22T16:32:12Biblioteca Digital de Teses e Dissertações da UFPB - Universidade Federal da Paraíba (UFPB)false
dc.title.none.fl_str_mv Investigação da atividade antifúngica e anti-biofilme de 2-cloro-n-fenilacetamida sobre Candida albicans e Candida parapsilosis resistentes ao fluconazol
title Investigação da atividade antifúngica e anti-biofilme de 2-cloro-n-fenilacetamida sobre Candida albicans e Candida parapsilosis resistentes ao fluconazol
spellingShingle Investigação da atividade antifúngica e anti-biofilme de 2-cloro-n-fenilacetamida sobre Candida albicans e Candida parapsilosis resistentes ao fluconazol
Diniz Neto, Hermes
Fungicidas
2-cloro-N-fenilacetamida
Biofilme
Candida spp.
Resistência antifúngica
Fungicides
2-chloro-N-phenylacetamide
Biofilm
Antifungal resistance
Mecanismo de ação
Mechanism of action
CNPQ::CIENCIAS BIOLOGICAS::FARMACOLOGIA
title_short Investigação da atividade antifúngica e anti-biofilme de 2-cloro-n-fenilacetamida sobre Candida albicans e Candida parapsilosis resistentes ao fluconazol
title_full Investigação da atividade antifúngica e anti-biofilme de 2-cloro-n-fenilacetamida sobre Candida albicans e Candida parapsilosis resistentes ao fluconazol
title_fullStr Investigação da atividade antifúngica e anti-biofilme de 2-cloro-n-fenilacetamida sobre Candida albicans e Candida parapsilosis resistentes ao fluconazol
title_full_unstemmed Investigação da atividade antifúngica e anti-biofilme de 2-cloro-n-fenilacetamida sobre Candida albicans e Candida parapsilosis resistentes ao fluconazol
title_sort Investigação da atividade antifúngica e anti-biofilme de 2-cloro-n-fenilacetamida sobre Candida albicans e Candida parapsilosis resistentes ao fluconazol
author Diniz Neto, Hermes
author_facet Diniz Neto, Hermes
author_role author
dc.contributor.none.fl_str_mv Lima, Edeltrudes de Oliveira
http://lattes.cnpq.br/9406572870167006
Guerra, Felipe Queiroga Sarmento
http://lattes.cnpq.br/4997951182162954
dc.contributor.author.fl_str_mv Diniz Neto, Hermes
dc.subject.por.fl_str_mv Fungicidas
2-cloro-N-fenilacetamida
Biofilme
Candida spp.
Resistência antifúngica
Fungicides
2-chloro-N-phenylacetamide
Biofilm
Antifungal resistance
Mecanismo de ação
Mechanism of action
CNPQ::CIENCIAS BIOLOGICAS::FARMACOLOGIA
topic Fungicidas
2-cloro-N-fenilacetamida
Biofilme
Candida spp.
Resistência antifúngica
Fungicides
2-chloro-N-phenylacetamide
Biofilm
Antifungal resistance
Mecanismo de ação
Mechanism of action
CNPQ::CIENCIAS BIOLOGICAS::FARMACOLOGIA
description Infections caused by the Candida genus, especially systemic ones, represent a challenge for public health due to high morbidity and mortality, high associated costs and difficulty in treatment with a good clinical prognosis. Candida albicans is the most frequent cause of this infection, however, the number of cases caused by non-albicans species such as C. parapsilosis has emerged, with a remarkable record of resistant strains. The search for new therapeutic alternatives becomes an important resource in the control of these infections and the use of some already known substances, such as 2-chloro-N-phenylacetamide, is a way to obtain potentially effective new products. Therefore, the antifungal potential of 2-chloro-N-phenylacetamide was investigated against fluconazole-resistant C. albicans and C. parapsilosis strains. The antifungal activity of 2-chloro-N-phenylacetamide was evaluated in vitro by the determination of the minimum inhibitory and fungicidal concentrations (MIC and MFC), inhibition of biofilm formation and its rupture, investigation of the possible mechanism of action, and association between this molecule and amphotericin B and fluconazole. The test product inhibited all strains of C. albicans and C. parapsilosis, with a MIC ranging from 128 to 256 μg.mL-1, and a MFC of 512 to 1,024 μg.mL-1. It also inhibited up to 92% of biofilm formation and rupture of up to 87% of preformed biofilm. However, 2-chloro-N-phenylacetamide did not promote antifungal activity by binding to cell membrane ergosterol, nor did it impair the integrity of the fungal cell wall. Antagonism has been observed when combining this substance with amphotericin B and fluconazole. The substance exhibited significant antifungal effects by inhibiting both planktonic cells and the biofilm of fluconazole-resistant strains. It is worth noting that its combination with other antifungals should be avoided and that its mechanism of action remains to be established.
publishDate 2022
dc.date.none.fl_str_mv 2022-11-19
2022-10-21
2023-01-31T20:44:09Z
2023-01-31T20:44:09Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/doctoralThesis
format doctoralThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://repositorio.ufpb.br/jspui/handle/123456789/26118
url https://repositorio.ufpb.br/jspui/handle/123456789/26118
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv Attribution-NoDerivs 3.0 Brazil
http://creativecommons.org/licenses/by-nd/3.0/br/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Attribution-NoDerivs 3.0 Brazil
http://creativecommons.org/licenses/by-nd/3.0/br/
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Universidade Federal da Paraíba
Brasil
Farmacologia
Programa de Pós-Graduação em Produtos Naturais e Sintéticos Bioativos
UFPB
publisher.none.fl_str_mv Universidade Federal da Paraíba
Brasil
Farmacologia
Programa de Pós-Graduação em Produtos Naturais e Sintéticos Bioativos
UFPB
dc.source.none.fl_str_mv reponame:Biblioteca Digital de Teses e Dissertações da UFPB
instname:Universidade Federal da Paraíba (UFPB)
instacron:UFPB
instname_str Universidade Federal da Paraíba (UFPB)
instacron_str UFPB
institution UFPB
reponame_str Biblioteca Digital de Teses e Dissertações da UFPB
collection Biblioteca Digital de Teses e Dissertações da UFPB
repository.name.fl_str_mv Biblioteca Digital de Teses e Dissertações da UFPB - Universidade Federal da Paraíba (UFPB)
repository.mail.fl_str_mv diretoria@ufpb.br|| diretoria@ufpb.br
_version_ 1801843004895395840